Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We surveyed a random sample of 200 primary care physicians from France, Germany, Italy, the Netherlands, and Spain, and 250 from the United Kingdom to determine their perceptions of heart failure treatment. Most physicians thought angiotensin-converting enzyme (ACE) inhibitors were effective in relieving symptoms and reducing mortality in heart failure, but many also thought these agents carried substantial risk. Despite evidence of benefit, ACE inhibitors were prescribed in only 47% to 62% of patients. These data suggest treatment decisions were dominated by perceptions of treatment risk rather than benefit.


Journal article


Cardiology Review

Publication Date





29 - 32